CN Patent

CN114341161A — 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途

Assigned to Protagonist Therapeutics Inc · Expires 2022-04-12 · 4y expired

What this patent protects

本发明提供了白细胞介素‑23受体的新型肽抑制剂，以及使用这些肽抑制剂治疗或预防多种疾病和病症(包括炎症性肠病)的相关组合物和方法。

USPTO Abstract

本发明提供了白细胞介素‑23受体的新型肽抑制剂，以及使用这些肽抑制剂治疗或预防多种疾病和病症(包括炎症性肠病)的相关组合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114341161A
Jurisdiction
CN
Classification
—
Expires
2022-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Protagonist Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.